Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells

Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting dr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Costa, M.P, Feitosa, A.C.S, Oliveira, F.C.E, Cavalcanti, B.C, Da Silva, E.N., Jr, Dias, G.G, Sales, F.A.M, Sousa, B.L, Barroso-Neto, I.L, Pessoa, C, Caetano, E.W.S, Di Fiore, S, Fischer, R, Ladeira, L.O, Freire, V.N
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Costa, M.P
Feitosa, A.C.S
Oliveira, F.C.E
Cavalcanti, B.C
Da Silva, E.N., Jr
Dias, G.G
Sales, F.A.M
Sousa, B.L
Barroso-Neto, I.L
Pessoa, C
Caetano, E.W.S
Di Fiore, S
Fischer, R
Ladeira, L.O
Freire, V.N
description Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting drug-loaded system against metastatic prostate cancer cells. The microcapsules presented appropriate morphological features and the presence of drug molecules in the microcapsules was confirmed by different methods. Spherical microcapsules with a size range of 1.03 ± 0.46 μm were produced with an encapsulation efficiency of approximately 19%. Classical molecular dynamics calculations provided an estimate of the typical adsorption energies of NβL on PLGA. Finally, the cytotoxic activity of NβL against PC3M human prostate cancer cells was demonstrated to be significantly enhanced when delivered by PLGA microcapsules in comparison with the free drug.
doi_str_mv 10.3390/molecules21070873
format Article
fullrecord <record><control><sourceid>fraunhofer_E3A</sourceid><recordid>TN_cdi_fraunhofer_primary_oai_fraunhofer_de_N_421877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_fraunhofer_de_N_421877</sourcerecordid><originalsourceid>FETCH-fraunhofer_primary_oai_fraunhofer_de_N_4218773</originalsourceid><addsrcrecordid>eNqdjD1OAzEQRt2kQAkHoJsLbNjNRtokXWTxJ0EUAb01OOONJa9nNXYQbjkSB-FMpKCgpvqkp_c-pa6aet626_p64ED2FCgtmrqrV117oT41xywcAh3gmQJhImAHO5bq-6sKOKI9ciR4K7B_vNvCk7fCI0r29vyzgS28ZMFMfQHHAg_DKPzuYw-6ZM784a3PBbBHH1OGvXDKZxs0RksCmkJIMzVxGBJd_u5ULW9vXvV95QRP8ciOxIziB5RiGL35gw9kdma5aFZd1_4z-wFy3GKc</addsrcrecordid><sourcetype>Institutional Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells</title><source>Fraunhofer-ePrints</source><creator>Costa, M.P ; Feitosa, A.C.S ; Oliveira, F.C.E ; Cavalcanti, B.C ; Da Silva, E.N., Jr ; Dias, G.G ; Sales, F.A.M ; Sousa, B.L ; Barroso-Neto, I.L ; Pessoa, C ; Caetano, E.W.S ; Di Fiore, S ; Fischer, R ; Ladeira, L.O ; Freire, V.N</creator><creatorcontrib>Costa, M.P ; Feitosa, A.C.S ; Oliveira, F.C.E ; Cavalcanti, B.C ; Da Silva, E.N., Jr ; Dias, G.G ; Sales, F.A.M ; Sousa, B.L ; Barroso-Neto, I.L ; Pessoa, C ; Caetano, E.W.S ; Di Fiore, S ; Fischer, R ; Ladeira, L.O ; Freire, V.N</creatorcontrib><description>Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting drug-loaded system against metastatic prostate cancer cells. The microcapsules presented appropriate morphological features and the presence of drug molecules in the microcapsules was confirmed by different methods. Spherical microcapsules with a size range of 1.03 ± 0.46 μm were produced with an encapsulation efficiency of approximately 19%. Classical molecular dynamics calculations provided an estimate of the typical adsorption energies of NβL on PLGA. Finally, the cytotoxic activity of NβL against PC3M human prostate cancer cells was demonstrated to be significantly enhanced when delivered by PLGA microcapsules in comparison with the free drug.</description><identifier>DOI: 10.3390/molecules21070873</identifier><language>eng</language><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,780,27860</link.rule.ids><linktorsrc>$$Uhttp://publica.fraunhofer.de/documents/N-421877.html$$EView_record_in_Fraunhofer-Gesellschaft$$FView_record_in_$$GFraunhofer-Gesellschaft$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Costa, M.P</creatorcontrib><creatorcontrib>Feitosa, A.C.S</creatorcontrib><creatorcontrib>Oliveira, F.C.E</creatorcontrib><creatorcontrib>Cavalcanti, B.C</creatorcontrib><creatorcontrib>Da Silva, E.N., Jr</creatorcontrib><creatorcontrib>Dias, G.G</creatorcontrib><creatorcontrib>Sales, F.A.M</creatorcontrib><creatorcontrib>Sousa, B.L</creatorcontrib><creatorcontrib>Barroso-Neto, I.L</creatorcontrib><creatorcontrib>Pessoa, C</creatorcontrib><creatorcontrib>Caetano, E.W.S</creatorcontrib><creatorcontrib>Di Fiore, S</creatorcontrib><creatorcontrib>Fischer, R</creatorcontrib><creatorcontrib>Ladeira, L.O</creatorcontrib><creatorcontrib>Freire, V.N</creatorcontrib><title>Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells</title><description>Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting drug-loaded system against metastatic prostate cancer cells. The microcapsules presented appropriate morphological features and the presence of drug molecules in the microcapsules was confirmed by different methods. Spherical microcapsules with a size range of 1.03 ± 0.46 μm were produced with an encapsulation efficiency of approximately 19%. Classical molecular dynamics calculations provided an estimate of the typical adsorption energies of NβL on PLGA. Finally, the cytotoxic activity of NβL against PC3M human prostate cancer cells was demonstrated to be significantly enhanced when delivered by PLGA microcapsules in comparison with the free drug.</description><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>AFSUM</sourceid><sourceid>E3A</sourceid><recordid>eNqdjD1OAzEQRt2kQAkHoJsLbNjNRtokXWTxJ0EUAb01OOONJa9nNXYQbjkSB-FMpKCgpvqkp_c-pa6aet626_p64ED2FCgtmrqrV117oT41xywcAh3gmQJhImAHO5bq-6sKOKI9ciR4K7B_vNvCk7fCI0r29vyzgS28ZMFMfQHHAg_DKPzuYw-6ZM784a3PBbBHH1OGvXDKZxs0RksCmkJIMzVxGBJd_u5ULW9vXvV95QRP8ciOxIziB5RiGL35gw9kdma5aFZd1_4z-wFy3GKc</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Costa, M.P</creator><creator>Feitosa, A.C.S</creator><creator>Oliveira, F.C.E</creator><creator>Cavalcanti, B.C</creator><creator>Da Silva, E.N., Jr</creator><creator>Dias, G.G</creator><creator>Sales, F.A.M</creator><creator>Sousa, B.L</creator><creator>Barroso-Neto, I.L</creator><creator>Pessoa, C</creator><creator>Caetano, E.W.S</creator><creator>Di Fiore, S</creator><creator>Fischer, R</creator><creator>Ladeira, L.O</creator><creator>Freire, V.N</creator><scope>AFSUM</scope><scope>E3A</scope></search><sort><creationdate>2016</creationdate><title>Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells</title><author>Costa, M.P ; Feitosa, A.C.S ; Oliveira, F.C.E ; Cavalcanti, B.C ; Da Silva, E.N., Jr ; Dias, G.G ; Sales, F.A.M ; Sousa, B.L ; Barroso-Neto, I.L ; Pessoa, C ; Caetano, E.W.S ; Di Fiore, S ; Fischer, R ; Ladeira, L.O ; Freire, V.N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-fraunhofer_primary_oai_fraunhofer_de_N_4218773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Costa, M.P</creatorcontrib><creatorcontrib>Feitosa, A.C.S</creatorcontrib><creatorcontrib>Oliveira, F.C.E</creatorcontrib><creatorcontrib>Cavalcanti, B.C</creatorcontrib><creatorcontrib>Da Silva, E.N., Jr</creatorcontrib><creatorcontrib>Dias, G.G</creatorcontrib><creatorcontrib>Sales, F.A.M</creatorcontrib><creatorcontrib>Sousa, B.L</creatorcontrib><creatorcontrib>Barroso-Neto, I.L</creatorcontrib><creatorcontrib>Pessoa, C</creatorcontrib><creatorcontrib>Caetano, E.W.S</creatorcontrib><creatorcontrib>Di Fiore, S</creatorcontrib><creatorcontrib>Fischer, R</creatorcontrib><creatorcontrib>Ladeira, L.O</creatorcontrib><creatorcontrib>Freire, V.N</creatorcontrib><collection>Fraunhofer-ePrints - FT</collection><collection>Fraunhofer-ePrints</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Costa, M.P</au><au>Feitosa, A.C.S</au><au>Oliveira, F.C.E</au><au>Cavalcanti, B.C</au><au>Da Silva, E.N., Jr</au><au>Dias, G.G</au><au>Sales, F.A.M</au><au>Sousa, B.L</au><au>Barroso-Neto, I.L</au><au>Pessoa, C</au><au>Caetano, E.W.S</au><au>Di Fiore, S</au><au>Fischer, R</au><au>Ladeira, L.O</au><au>Freire, V.N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells</atitle><date>2016</date><risdate>2016</risdate><abstract>Prostate cancer is one of the most common malignant tumors in males and it has become a major worldwide public health problem. This study characterizes the encapsulation of Nor-β-lapachone (NβL) in poly(d,l-lactide-co-glycolide) (PLGA) microcapsules and evaluates the cytotoxicity of the resulting drug-loaded system against metastatic prostate cancer cells. The microcapsules presented appropriate morphological features and the presence of drug molecules in the microcapsules was confirmed by different methods. Spherical microcapsules with a size range of 1.03 ± 0.46 μm were produced with an encapsulation efficiency of approximately 19%. Classical molecular dynamics calculations provided an estimate of the typical adsorption energies of NβL on PLGA. Finally, the cytotoxic activity of NβL against PC3M human prostate cancer cells was demonstrated to be significantly enhanced when delivered by PLGA microcapsules in comparison with the free drug.</abstract><doi>10.3390/molecules21070873</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.3390/molecules21070873
ispartof
issn
language eng
recordid cdi_fraunhofer_primary_oai_fraunhofer_de_N_421877
source Fraunhofer-ePrints
title Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A27%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-fraunhofer_E3A&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Controlled%20Release%20of%20Nor-%CE%B2-lapachone%20by%20PLGA%20Microparticles:%20A%20Strategy%20for%20Improving%20Cytotoxicity%20against%20Prostate%20Cancer%20Cells&rft.au=Costa,%20M.P&rft.date=2016&rft_id=info:doi/10.3390/molecules21070873&rft_dat=%3Cfraunhofer_E3A%3Eoai_fraunhofer_de_N_421877%3C/fraunhofer_E3A%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true